Improved myocardial scar visualization with fast free-breathing motion-compensated black-blood T


Journal

Diagnostic and interventional imaging
ISSN: 2211-5684
Titre abrégé: Diagn Interv Imaging
Pays: France
ID NLM: 101568499

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 27 04 2022
revised: 12 07 2022
accepted: 19 07 2022
pubmed: 13 8 2022
medline: 6 12 2022
entrez: 12 8 2022
Statut: ppublish

Résumé

Clinical guidelines recommend the use of bright-blood late gadolinium enhancement (BR-LGE) for the detection and quantification of regional myocardial fibrosis and scar. This technique, however, may suffer from poor contrast at the blood-scar interface, particularly in patients with subendocardial myocardial infarction. The purpose of this study was to assess the clinical performance of a two-dimensional black-blood LGE (BL-LGE) sequence, which combines free-breathing T Extended phase graph simulations and phantom experiments were performed to investigate the performance of the motion-correction algorithm and to assess the black-blood properties of the proposed sequence. Fifty-one patients (37 men, 14 women; mean age, 55 ± 15 [SD] years; age range: 19-81 years) with known or suspected cardiac disease prospectively underwent free-breathing T BL-LGE images were acquired with full ventricular coverage in 115 ± 25 (SD) sec (range: 64-160 sec). Image quality was significantly higher on free-breathing BL-LGE imaging than on its breath-held BR-LGE counterpart (3.6 ± 0.7 [SD] [range: 2-4] vs. 3.9 ± 0.2 [SD] [range: 3-4]) (P <0.01) and was graded as diagnostic for 44/51 (86%) patients. The mean scar-to-myocardium and scar-to-blood relative contrasts were significantly higher on BL-LGE images (P < 0.01 for both). The extent of LGE was larger on BL-LGE (median, 5 segments [IQR: 2, 7 segments] vs. median, 4 segments [IQR: 1, 6 segments]) (P < 0.01), the method being particularly sensitive in segments with LGE involving the subendocardium or papillary muscles. In eight patients (16%), BL-LGE could ascertain or rule out a diagnosis otherwise inconclusive on BR-LGE. Free-breathing T

Identifiants

pubmed: 35961843
pii: S2211-5684(22)00142-5
doi: 10.1016/j.diii.2022.07.003
pii:
doi:

Substances chimiques

Gadolinium AU0V1LM3JT
Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-617

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Soumaya Sridi (S)

Department of Cardiovascular Imaging, Groupe Hospitalier Sud, CHU Bordeaux, 33000, Pessac, France. Electronic address: soumayasridi@gmail.com.

Marta Nuñez-Garcia (M)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France.

Maxime Sermesant (M)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France; INRIA, Université Côte d'Azur, Sophia Antipolis, 06902, Valbonne, France.

Aurélien Maillot (A)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France.

Dounia El Hamrani (DE)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France.

Julie Magat (J)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France.

Jérôme Naulin (J)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France.

François Laurent (F)

Department of Cardiovascular Imaging, Groupe Hospitalier Sud, CHU Bordeaux, 33000, Pessac, France.

Michel Montaudon (M)

Department of Cardiovascular Imaging, Groupe Hospitalier Sud, CHU Bordeaux, 33000, Pessac, France.

Pierre Jaïs (P)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France; Department of Cardiac Electrophysiologhy, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, 33600, Pessac, France.

Matthias Stuber (M)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland; Center for Biomedical Imaging (CIBM), 1015, Lausanne, Switzerland.

Hubert Cochet (H)

Department of Cardiovascular Imaging, Groupe Hospitalier Sud, CHU Bordeaux, 33000, Pessac, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France.

Aurélien Bustin (A)

Department of Cardiovascular Imaging, Groupe Hospitalier Sud, CHU Bordeaux, 33000, Pessac, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Université de Bordeaux, INSERM U1045, 33600, Pessac, France; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH